Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles-Reference-Cited by-同舟云学术

Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles

Published:2017-05-24 Issue:5 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Mochtar Monique H¹,Danhof Nora A¹,Ayeleke Reuben Olugbenga²,Van der Veen Fulco¹,van Wely Madelon¹

Affiliation:

1. Academic Medical Center, University of Amsterdam; Center for Reproductive Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ

2. University of Auckland; Department of Obstetrics and Gynaecology; Private Bag 92019 Auckland New Zealand

Publisher

Wiley

Subject

Pharmacology (medical)

Reference75 articles.

1. Abdelmassih V Salgueiro R Abdelmassih C Carizza C Less miscarriage rate using LH (rLH) in GnRH agonists long protocols Twenty-Second Annual Meeting of the European Society of Human Reproduction and Embryology; 2006 June 18-21 Prague ESHRE 2006

2. Allegra A Pane A Marino A Scaglione P Ruvolo G Volpes A Is rLH useful in the treatment of infertile poor prognosis patients undergoing IVF cycles? A preliminary report of a controlled trial Abstracts of the 27th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE); 2011 July 3-6; Stockholm 2011 i298 9

3. The effect of exogenous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian hyperstimulation in pituitary-suppressed women undergoing assisted reproduction;Balasch;Journal of Assisted Reproductive Genetics,2001

4. Ovarian response and pregnancy outcome in poor-responder women: a randomised controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles;Barrenetxea;Fertility and Sterility,2008

5. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders;Berkkanoglu;Fertilility and Sterility,2007

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human luteinizing hormone increases endometrial thickness in women undergoing assisted fertility treatments: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-07-29

2. Sperm‐borne miR‐34c‐5p and miR‐191‐3p as markers for sperm motility and embryo developmental competence;Andrology;2024-07-24

3. Impact of stimulation with luteinizing hormone activity on IVF outcomes in patients with polycystic ovary syndrome;Journal of the Turkish-German Gynecological Association;2024-06-13

4. Follitropin delta combined with menotropin in patients at risk for poor ovarian response during in vitro fertilization cycles: a prospective controlled clinical study;Reproductive Biology and Endocrinology;2024-01-02

5. A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity;Pharmaceuticals;2023-11-02